Overseas studies under increasing scrutiny

12/1/2008 | Wall Street Journal, The

Western drugmakers and regulators are under mounting pressure to ensure the safety of clinical trials conducted in developing countries after reports of death and complications in participants. Some experts are concerned about possible violations of clinical-testing rules, while others worry that companies may be taking advantage of individuals desperate to join studies. Drugmakers said they follow the rules when conducting trials abroad, including securing government authorization and routinely inspecting sites.

View Full Article in:

Wall Street Journal, The

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Sr. Regulatory Specialist, Biotech Center of Expertise
BASF, The Chemical Co.
San Diego, CA
Food Lawyer
Wayzata, MN
Director of Clinical Research
Regenesis Biomedical, Inc.
Scottsdale, AZ
Meridian Health Plan
Detroit, MI
Assistant Vice President - Dental Director
Bridgewater, NJ